Lyophilization Technology
GEA’s LYOVAC® industrial-scale freeze dryers are built to customer specifications and are available with production areas of 1–60 m² and condenser capacities of more than 1000 kg.
The LYOVAC® production-scale freeze dryer is a best-in-class solution for the pharmaceutical industry. In close collaboration with our customers, we design, build and customize them according to specific requirements.
LYOVAC® freeze dryers and their peripherical equipment can be arranged either on one or multiple floors. The condenser can be situated next to the drying chamber or directly underneath it. Either way, it ensures both easy access to the machine parts and complete separation between the cleanroom and the technical area.
A unique feature is the high quality of the in-house manufactured shelves. This is the heart of the machine and ensures an optimal temperature distribution, unform result and, consequently, the essential final product quality.
Several features of the LYOVAC® (see below) support the fastest processing times in the industry, offering increased productivity and commercial benefits.
The LYOVAC® range is also available using GEA’s unique Fast Track manufacturing process. Depending on the complexity of the installation and based on previously completed projects, it’s possible to have a system up and running in less than a year.
Virtual Twin of a LYOVAC Freeze Dryer

Extending its range of LYOVAC™ Freeze Dryers, GEA now offers both integrated and standalone equipment for the production of small-scale batches and formulation or process development.

LYOPLUS™ mass spectrometer is a multi-purpose measurement device for pharmaceutical freeze dryers.

SMART LYO™ Freeze Dryers help reduce the cost of freeze drying while maintaining quality and performance, making validation and documentation easier and reducing delivery times.

ALUS® Automatic Load & Unload Systems minimize the risk of operator/product contamination while loading and unloading a freeze dryer.
GEA centrifuges enable wastewater reuse, resource recovery, and water security by turning biosolids into value in a world facing growing water scarcity.
Last year was not a year of hyped-up headlines for alternative proteins. Perhaps that is precisely why it was an important year for food biotech, the biotechnology behind everyday foods and ingredients. While the sector worked through a difficult funding environment, approvals were still granted, pilot lines set up and new platforms tested in the background. In short: headlines are turning into infrastructure. Frederieke Reiners heads GEA’s New Food business. She and her team work at the intersection of biotechnology and industrial food production. In this interview, she takes us on a world tour of food biotech in seven questions.
Pets are family – and owners expect premium, transparent and sustainable nutrition. Freeze-drying, powered by GEA technology, helps pet food makers deliver.